Alcyone Lifesciences said today that its ThecaFlex DRx system won breakthrough device status from the FDA.
The Lowell, Mass.-based company’s system features an implantable subcutaneous port and intrathecal catheter used to provide access for cerebrospinal fluid aspiration and infusion of therapies.
Get the full story at our sister site, Drug Delivery Business News.
The post Alcyone wins breakthrough device status for delivery device appeared first on MassDevice.
from MassDevice https://ift.tt/2ETSlOk
Cap comentari:
Publica un comentari a l'entrada